Duration : Sessions range from 4070 minutes, depending on the treatment area
Brand name Active drug Indication Approval year Max approved dose Ozempic Semaglutide Type 2 diabetes (glycemic control) 2017 2 mg/week Wegovy Semaglutide Chronic weight management (BMI 30 or 27 + comorbidity) 2021 2.4 mg/week Rybelsus Semaglutide Type 2 diabetes (oral daily tablet) 2019 14 mg/day (oral) Mounjaro Tirzepatide Type 2 diabetes (glycemic control) 2022 15 mg/week Zepbound Tirzepatide Chronic weight management (BMI 30 or 27 + comorbidity) 2023 15 mg/week Table 1 FDA-approved indications for semaglutide and tirzepatide brand names

GLP-1 medications (semaglutide, tirzepatide, and more) Personalized health coaching & nutritional guidance Scales, Metabolic tracking + progress check-ins Skin and body contouring add-ons for sagging prevention Hair health support if needed Ongoing care from licensed professionals Aurora & Denver Residents: Medical Weight Loss That Works Around Your Life At ZenVita MedSpa in Aurora, we understand that weight loss looks different for everyone and that Colorado living comes with its own set of challenges
A comprehensive meta-analysis published in Diabetes Care reviewed data from randomised controlled trials and found no significant increase in pancreatic cancer incidence among those using GLP-1 medications compared to other diabetes treatments or placebo
Healthcare providers recommend Zepbound for individuals who are obese or overweight and have weight-related medical conditions such as hypertension, dyslipidemia, type 2 diabetes mellitus, obstructive sleep apnea, or cardiovascular disease to help them reduce and maintain weight